Keywords: Paion AG, Anesthesiology, Remimazolam, Edison Investment

Paion now moving in new direction, analysts note

Article | 18 March 2012

Print This

German drug developer Paion AG (FSE: PA8) is moving beyond the bat saliva-derived stroke project desmoteplase, recently sold to Danish ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in